Login / Signup

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center.

Paolo SolidoroStefania NicolaIrene RidolfiGiorgio Walter CanonicaFrancesco BlasiPierluigi PaggiaroEnrico HefflerDiego BagnascoFilippo PatruccoFulvia RibollaCaterina BuccaGiovanni RollaCarlo AlberaLuisa Brussino
Published in: Biomedicines (2022)
This real-life study confirms the long-term efficacy of biologics in most SEA patients and indicates that even in non-responders to a first biological drug, it is worth trying a second one. It is hoped that the availability of additional biologics with different targets will help improve the personalization of SEA therapy.
Keyphrases